Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC13643 structure
    GC13643c-di-AMP
    CAS: 54447-84-6
    纯度: >98.50% / >95.00%

    C-di-AMP是STING(刺激内质网的蛋白)的激动剂,通过与该跨膜蛋白结合,激活TBK3-IRF3信号通路,进而引发I型IFN和TNF的产生。

  • GC13662 structure
    GC13662(±)-Lisofylline
    CAS: 6493-06-7
    纯度: >98.00%

    A potent inhibitor of phosphatidic acid generation

  • GC13693 structure
    GC13693Omaveloxolone (RTA-408)
    CAS: 1474034-05-3
    纯度: >99.00% / >98.00%

    Omaveloxolone (RTA-408)是一种抗氧化炎症调节剂(AIM),可激活Nrf2并抑制一氧化氮(NO)的生成。

  • GC13765 structure
    GC13765EIT hydrobromide
    CAS: 1071-37-0

    A potent inhibitor of NOS

  • GC13795 structure
    GC13795Isobavachalcone
    CAS: 20784-50-3
    纯度: >98.00%

    A chalcone and flavonoid with diverse biological activities

  • GC13800 structure
    GC13800Polyinosinic-polycytidylic Acid (potassium salt)
    CAS: 31852-29-6
    纯度: >95.00%

    激活 TLR3 和视黄酸诱导基因 1 (RIG-1) 样受体的合成 dsRNA

  • GC13816 structure
    GC13816Cannabidiol dimethyl ether
    CAS: 1242-67-7

    Pomalidomide - Peg2-azide is a synthetic E3 ligand -linker conjugate containing Pomalidomide based cereblon ligand and 2-unit PEG linker.

  • GC13840 structure
    GC13840Stachydrine (hydrochloride)
    CAS: 4136-37-2
    纯度: >97.00%

    A pyrrolidine betaine with anticancer and cardioprotective effects

  • GC13859 structure
    GC13859Z-DEVD-AFC
    CAS: 1135416-11-3

    A caspase-3 fluorogenic substrate

  • GC13926 structure
    GC13926BMS-345541(free base)
    CAS: 445430-58-0
    纯度: >99.50%

    BMS-345541(free base) 是 IKK 催化亚基的选择性抑制剂 (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM)。 BMS-345541(游离碱)结合在 IKK 的变构位点。

  • GC13941 structure
    GC13941Cyclosporin A
    CAS: 59865-13-3
    纯度: >98.00% / >97.00% / >99.00%

    Cyclosporin A是一种免疫抑制剂,其主要的三个靶点是亲环蛋白、钙调神经磷酸酶和转运蛋白,其抑制亲环蛋白A和钙调神经磷酸酶活性的IC 50 分别为360nM和5nM。

  • GC13982 structure
    GC139827-NINA
    CAS: 161467-34-1

    non-selective NOS inhibitor

  • GC14049 structure
    GC14049(-)-Epigallocatechin gallate (EGCG)
    CAS: 989-51-5
    纯度: >99.50% / >99.00% / >98.00%

    (-)-Epigallocatechin Gallate sulfate (EGCG) 是绿茶中的一种主要多酚,可抑制细胞增殖并诱导细胞凋亡。

  • GC14076 structure
  • GC14231 structure
    GC14231AR-C 102222
    CAS: 253771-21-0

    iNOS inhibitor

  • GC14254 structure
    GC14254CU-CPT22
    CAS: 1416324-85-0
    纯度: >98.00%

    CU-CPT22是一种有效的Toll样受体1和2(LR1/2)蛋白复合物抑制剂,可与合成的三酰化脂蛋白(Pam3CSK4)竞争结合TLR1/2,Ki值为0.41µM。CU-CPT22可阻断Pam3CSK4诱导的TLR1/2激活,IC 50 值为0.58µM。

  • GC14282 structure
    GC14282AKBA (3-acetyl-11-keto-β-Boswellic Acid)
    CAS: 67416-61-9
    纯度: >98.00%

    AKBA (3-acetyl-11-keto-β-Boswellic Acid)是一种五环三萜酸,能够有效地非竞争性地抑制5-脂氧合酶(5-lipoxygenase, 5-LOX),具有抗炎、抗肿瘤、神经保护等多种生物活性。

  • GC14498 structure
    GC14498AP20187
    CAS: 195514-80-8
    纯度: >98.00%

    AP20187是一种合成的二聚体化合物,能够诱导含有FKBP(FK506结合蛋白)结构域的蛋白质发生二聚化。AP20187在多种生物学研究和治疗中被用于控制蛋白质-蛋白质相互作用和调节细胞过程。

  • GC14553 structure
    GC14553Resveratrol
    CAS: 501-36-0
    纯度: >99.50%

    白藜芦醇(转-白藜芦醇;SRT501)是一种植物抗菌素。

  • GC14586 structure
    GC14586Efaproxiral Sodium
    CAS: 170787-99-2
    纯度: >99.50%

    An allosteric hemoglobin modifier

  • GC14622 structure
    GC14622Diclofenac Potassium
    CAS: 15307-81-0
    纯度: >98.00%

    Diclofenac Potassium是一种强效的非选择性环氧化酶(COX)抑制剂,在CHO细胞中对人源COX-1和COX-2的IC₅₀值分别为4nM和1.3nM;对羊源COX-1和COX-2的IC₅₀值分别为5.1μM和0.84μM。

  • GC14627 structure
    GC146271,4-PBIT (dihydrobromide)
    CAS: 157254-60-9

    A potent inhibitor of iNOS and nNOS

  • GC14710 structure
    GC14710Poly(I:C)
    CAS: 24939-03-5
    纯度: >91.10% / >90.00%

    聚(I:C)是一种合成的双链RNA类似物,是一种免疫刺激剂,可作为最强效的干扰素(IFN)诱导剂。

  • GC14727 structure
    GC14727CCCP
    CAS: 555-60-2
    纯度: >98.00% / >99.50%

    Carbonylcyanide-3-chlorophenylhydrazone (CCCP) 是一种质子载体,可导致线粒体内膜中的质子梯度解偶联,从而抑制 ATP 合成速率。